The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.

[1]  A. Mast,et al.  Alternatively spliced isoforms of tissue factor pathway inhibitor. , 2010, Thrombosis research.

[2]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[3]  E. Egorina,et al.  Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. , 2008, Blood.

[4]  M. Ghosh,et al.  Fibronectin‐adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin‐stimulated monocytes primarily express tissue factor: physiologic and pathologic implications , 2007, Journal of thrombosis and haemostasis : JTH.

[5]  G. Broze,et al.  Comparison of cell‐surface TFPIα and β , 2005, Journal of thrombosis and haemostasis : JTH.

[6]  F. Watzinger,et al.  Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program , 2003, Leukemia.

[7]  G. Broze,et al.  Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor , 2003, Circulation.

[8]  H. Coenraad Hemker,et al.  Calibrated Automated Thrombin Generation Measurement in Clotting Plasma , 2003, Pathophysiology of Haemostasis and Thrombosis.

[9]  M. Andrassy,et al.  Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. , 2001, Blood.

[10]  V. Fuster,et al.  Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.

[11]  Y. Miyagi,et al.  Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[12]  P. Cornillet‐Lefèbvre,et al.  Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation.Response of nonadherent cells to lipopolysaccharide , 1999, Transfusion.

[13]  V. Fuster,et al.  Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.

[14]  M. T. Madsen,et al.  Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[15]  B. Osterud,et al.  Sites of Tissue Factor Pathway Inhibitor (TFPI) and Tissue Factor Expression under Physiologic and Pathologic Conditions , 1995, Thrombosis and Haemostasis.

[16]  J. Hansen,et al.  Retention of phagocytic functions in cryopreserved human monocytes , 1995, Journal of leukocyte biology.

[17]  A. Camm,et al.  Increased monocyte tissue factor expression in coronary disease. , 1995, British heart journal.

[18]  L. Osnes,et al.  Procoagulant and profibrinolytic activities of cryopreserved human monocytes. , 1994, Thrombosis research.

[19]  M. McGee,et al.  Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation , 1994, The Journal of experimental medicine.

[20]  P. Reitsma,et al.  Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[21]  S. Rapaport,et al.  Initiation and regulation of tissue factor-dependent blood coagulation. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  B. Osterud.  Platelet activating factor enhancement of lipopolysaccharide‐induced tissue factor activity in monocytes: requirement of platelets and granulocytes , 1992, Journal of leukocyte biology.

[23]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[24]  H. Saito,et al.  Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Kathleen M. Smith,et al.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Rapaport,et al.  Studies of the Factor Xa-Dependent Inhibitor of Factor VIIa/Tissue Factor (Extrinsic Pathway Inhibitor) from Cell Supernates of Cultured Human Umbilical Vein Endothelial Cells , 1989, Thrombosis and Haemostasis.

[27]  S. Rapaport,et al.  Modifications of Extrinsic Pathway Inhibitor (EPI) and Factor Xa that Affect their Ability to Interact and to Inhibit Factor Vila/Tissue Factor: Evidence for a Two-Step Model of Inhibition , 1988, Thrombosis and Haemostasis.

[28]  J. Miletich,et al.  Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. , 1988, The Journal of biological chemistry.

[29]  J. Miletich,et al.  The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action , 1988 .

[30]  T. Flægstad,et al.  Increased Tissue Thromboplastin Activity in Monocytes of Patients with Meningococcal Infection: Related to an Unfavourable Prognosis , 1983, Thrombosis and Haemostasis.

[31]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Green,et al.  Proceedings: A more uniform measurement of factor VIII inhibitors. , 1975, Thrombosis et diathesis haemorrhagica.

[33]  J. Oliver,et al.  TFPIβ, a Second Product from the Mouse Tissue Factor Pathway Inhibitor (TFPI) Gene , 1999, Thrombosis and Haemostasis.

[34]  P. Kierulf,et al.  Lipopolysaccharide-instructed, cryopreserved, human monocytes sequentially convert plasma fibrinogen to fibrin and lyse the fibrin formed. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.